Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.

Minerva endocrinologica

Volumn 32, Issue 2, 2007, Pages 79-86

  Vilar, L ^a   Naves, L A ^a   Freitas, M C ^a   Lima, M ^a   Canadas, V ^a   Albuquerque, J L ^a   Lyra, R ^a   Azevedo, M F ^a   Casulari, L A ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE RECEPTOR BLOCKING AGENT; PROLACTIN;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; IMPOTENCE; MALE; MASS SCREENING; MENSTRUATION DISORDER; MIDDLE AGED; PREDICTION AND FORECASTING; PROLACTINOMA; REPRODUCIBILITY; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; DOPAMINE ANTAGONISTS; FEMALE; GALACTORRHEA; HUMANS; HYPERPROLACTINEMIA; IMPOTENCE; MALE; MASS SCREENING; MENSTRUATION DISTURBANCES; MIDDLE AGED; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROLACTIN; PROLACTINOMA; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 34948905349     PISSN: 03911977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)